Aethlon Medical Announces Appointment of Rod Kenley to Its Board of... (s are immobilized around approximately 2...)

Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors

Date:10/19/2010

s are immobilized around approximately 2800 porous hollow fibers that run the interior length of our device. The resulting design provides us the novel ability to separate both exosome and viral targets away from blood cells so they can then be selectively and permanently removed from the circulatory system. In application, blood circulation is established into the Hemopurifier® via a catheter or other blood access device. Once blood flow has been established, treatment benefit is immediate as the entire circulatory system can pass through the Hemopurifier® in as little as 15 minutes.

Our wholly owned subsidiary, Exosome Sciences, Inc. (ESI) is focused on the development of exosome-targeted products and services that improve cancer diagnosis, provide post-treatment cancer surveillance, and aid in the discovery of biomarkers that allow doctors to optimize patient therapy. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed online at www.aethlonmedical.com.Contacts:James A. JoyceChairman, CEO858.459.7800 x301jj@aethlonmedical.comJohn P. SalvadorDirector, Communications & Investor Relations858.459.7800 x307jps@aethlonmedical.comJon CunninghamRedChip Companies, Inc.800.733.2447 x107jon@redchip.com
'/>"/>

SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009
2. Aethlon Medical Announces Presentation of Hepatitis-C (HCV) Clinical Data at 42nd Annual American Society of Nephrology (ASN) Conference
3. Aethlon Medical Releases Medical Device Data Against the H1N1 Swine Flu Virus
4. Aethlon Medical Discloses Live Webcast of Todays BIOCOM Presentation
5. Aethlon Medical Announces Expansion of Hepatitis C Virus (HCV) Treatment Programs
6. Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program
7. Aethlon Medical to Present at Rodman & Renshaw Annual Global Investment Conference
8. Aethlon Medical Reestablishes Biodefense Programs
9. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report

Post Your Comments:

(Date:6/19/2013)... Israel , June 19, 2013 ... a phase I study in volunteers, and preliminary results ... of ND0612, were presented at the 2013 International Congress ... proprietary levodopa/carbidopa liquid drug formula under development for continuous ... maintain constant levodopa plasma concentrations. ND0612 has ...

(Date:6/19/2013)... Life Technologies Corporation (NASDAQ: ... Suzhou Ribo Life Sciences (Ribo) the exclusive rights ... China using Life,s Invivofectamine® Rx ... in combination with Invivofectamine® Rx to create a ... high unmet medical need in the Chinese healthcare ...

(Date:6/19/2013)... Juni 2013 Specialty Coating ... Entwicklung von SCS microRESIST™, einer antimikrobiellen ... Beschichtung mit Parylene gelungen ist. SCS ... Parylene mit antimikrobiellen Eigenschaften und erlaubt ... auf beschichteten medizinischen Geräten. ...

Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5 NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6 Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2 Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3 Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4 Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2

[0] NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease [0] Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China [0] Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt

... TARRYTOWN, N.Y. and BERLIN, April 8, 2011 ... and Bayer HealthCare today announced that they have initiated ... the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic ... certain eye diseases, in the treatment of Diabetic Macular ...

... Texas, April 7, 2011 Assured Pharmacy (APHY: pinksheets), ... more than 3,000 sufferers of chronic pain, has filed ... to effect a 1-for-180 reverse stock split of the ... reverse stock split in the number of issued and ...

Cached Medicine Technology:Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 2 Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 3 Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 4 Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 5 Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema 6 Assured Pharmacy Announces Reverse Stock Split 2 Assured Pharmacy Announces Reverse Stock Split 3

Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema Assured Pharmacy Announces Reverse Stock Split

(Date:6/19/2013)... June 19, 2013 Daily Gossip issued a ... training method will be published on their website at ... the article to inform readers about the information they will ... by reporters working at Daily Gossip, the article is a ... , Hiller has understood during the vast research he ...

(Date:6/19/2013)... June 19, 2013 Researchers from the ... demonstrated several new studies at ENDO 2013, The ... June 15-18 in San Francisco. , Mount Sinai researchers ... the role of prostastic acid phosphatase (PAP) in Prostate ... stimulate the thyroid gland; revealed the prevalence of primary ...

(Date:6/19/2013)... Texas (PRWEB) June 19, 2013 ... today announced its intent to purchase privately ... Florida, a leader in wheelchair accessible vehicle sales, ... of Auto Mobility Sales, Inc compliments and expands ... wheelchair accessible mobility dealers . The acquisition ...

(Date:6/19/2013)... CCA , America's leader in ... to Vice President, Health Services, effective June 8, 2013. ... Services for CCA. He will replace the retiring ... privilege to lead CCA's dedicated team of health care ... society and our partners as we provide effective care ...

(Date:6/19/2013)... Carlsbad, CA (PRWEB) June 19, 2013 ... , DHSc, DC, MS, explains why such seemingly minor ... anxiety, or concussions are vital red flags. They indicate ... risk for multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and ... , released in June 2013 by Elephant Press is ...

Breaking Medicine News(10 mins):Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 2 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 3 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 4 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 5 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 6 Health News:Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease 7 Health News:HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc. 2 Health News:CCA Names Dr. John Baxter Vice President, Health Services 2 Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2 Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3

[0] The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training [0] Diabetes Patients That Bring Glucose Meters to Doctor Visits Have Better Control Over Their Disease [0] HASCO Medical, Inc. to Acquire Auto Mobility Sales, Inc.[0] CCA Names Dr. John Baxter Vice President, Health Services [0] Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later

... revenue of $21.9 million versus $23.8 million ... in the same quarter last year. - On target to ... Supplement ... (Nasdaq: NAII ), a leading,formulator, manufacturer and marketer of customized nutritional,supplements, today ...

... patients are seeing rectal cancer specialists at similar rates, ... or radiation therapy, according to a new study from ... study found blacks were 23 percent less likely to ... likely to receive radiation therapy than whites. , Although ...

... CT for false positives, study found , , TUESDAY, May 13 ... head and neck cancer may not boost a patient,s odds ... disease, new findings suggest. , Positron emission tomography with a ... commonly used to check whether head and neck squamous cell ...

... (Nasdaq: UAHC ), which owns and provides ... in,Tennessee, today announced financial results for its third ... 82 percent to $8.3 million for the third ... of $4.6 million for,the third quarter of the ...

... IRIDEX,Corporation (Nasdaq: IRIX ) today reported financial results for ... for the first quarter of 2008 was $11.5 million, an ... of 2007. The,Company,s net loss was $0.9 million or $0.10 ... a net loss of $4.9 million or $0.61 per,diluted share ...

... Alternatives Ongoing; Company Prepares for, Potential 2008 Launch of MOXATAG; Keflex ... ... in Quarter, GERMANTOWN, Md., May 13 MiddleBrook,Pharmaceuticals, ... commercializing novel anti-infective products, today,announced financial and operational results for the ...

Natural Alternatives International, Inc. Announces Third Quarter Results Blacks not receiving chemotherapy for rectal cancer, despite seeing cancer specialists High-Tech Imaging No Better for Diagnosing Head/Neck Cancers United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results IRIDEX Reports First Quarter 2008 Financial Results MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results

Each handle is designed to fit a specific trephine size....

... of German Craftsmanship have ... instrumentation in the world. ... available to you! Only ... Meisterbrief certificate, which requires ...

... Centuries of German ... finest surgical instrumentation in ... makes them available to ... the coveted Meisterbrief certificate, ...

... Ophthalmic Products are constructed of ... lint-free MEROCEL polyvinyl acetal sponge. ... be beneficial to both surgeon ... and yet firm enough to ...

Medicine Products:

8.00mm Open Trephine Handle MVR Chuck Handle (for 20 Ga Stiletto Blade)Schepens Depressor 8.0mm Wide Tip Thimble Size 12 Yavitz Flap Cover